The clinical study in France evaluated the safety and feasibility of Robocath’s robotic-assisted coronary intervention platform across complex cardiac cases.
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
Bajaj joins Health Prime after a long and progressive tenure at Concentrix
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients
The early-stage study will test the drug’s safety, tolerability and biological effects in humans
Subscribe To Our Newsletter & Stay Updated
